These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 39025463
1. Baicalein suppresses Coxsackievirus B3 replication by inhibiting caspase-1 and viral protease 2A. Dong Y, Shao E, Li S, Wang R, Wang D, Wang L, Yang H, He Y, Luan T, Chen Y, Wang Y, Lin L, Wang Y, Zhong Z, Zhao W. Virol Sin; 2024 Aug; 39(4):685-693. PubMed ID: 39025463 [Abstract] [Full Text] [Related]
2. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication. Zhao Y, Yan K, Wang Y, Cai J, Wei L, Li S, Xu W, Li M. Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210 [Abstract] [Full Text] [Related]
3. Fructus Amomi Cardamomi Extract Inhibit Coxsackievirus-B3 Induced Myocarditis in Murine Myocarditis Model. Lee YG, Park JH, Jeon ES, Kim JH, Lim BK. J Microbiol Biotechnol; 2016 Nov 28; 26(11):2012-2018. PubMed ID: 27558433 [Abstract] [Full Text] [Related]
7. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L, He X, Gao B, Xiong S. J Virol; 2015 Oct 25; 89(20):10512-23. PubMed ID: 26269170 [Abstract] [Full Text] [Related]
8. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, Tschöpe C, Klingel K, Kurreck J, Beling A, Fechner H. Circ Heart Fail; 2019 Nov 25; 12(11):e005250. PubMed ID: 31718319 [Abstract] [Full Text] [Related]
9. N-Acetylcysteine Inhibits Coxsackievirus B3 Replication by Downregulating Eukaryotic Translation Elongation Factor 1 Alpha 1. Wang Y, Luan T, Wang L, Feng D, Dong Y, Li S, Yang H, Chen Y, Fei Y, Lin L, Pan J, Zhong Z, Zhao W. Viruses; 2024 Sep 23; 16(9):. PubMed ID: 39339978 [Abstract] [Full Text] [Related]
10. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. Yun SH, Lee WG, Kim YC, Ju ES, Lim BK, Choi JO, Kim DK, Jeon ES. J Infect Dis; 2012 Feb 01; 205(3):491-7. PubMed ID: 22207647 [Abstract] [Full Text] [Related]
11. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma. Zhang Y, Zhu H, Huang C, Cui X, Gao Y, Huang Y, Gong W, Zhao Y, Guo S. J Cardiovasc Pharmacol; 2006 Feb 01; 47(2):190-5. PubMed ID: 16495755 [Abstract] [Full Text] [Related]
12. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice. Stein EA, Pinkert S, Becher PM, Geisler A, Zeichhardt H, Klopfleisch R, Poller W, Tschöpe C, Lassner D, Fechner H, Kurreck J. J Infect Dis; 2015 Feb 15; 211(4):613-22. PubMed ID: 25193982 [Abstract] [Full Text] [Related]
13. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice. Jiang Y, Zhu R, Luo L, Mu Q, Zhu Y, Luo H, Zou X, Shen X. Intervirology; 2015 Feb 15; 58(6):343-9. PubMed ID: 26829552 [Abstract] [Full Text] [Related]
14. A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts. Yuan J, Cheung PK, Zhang H, Chau D, Yanagawa B, Cheung C, Luo H, Wang Y, Suarez A, McManus BM, Yang D. Lab Invest; 2004 Jun 15; 84(6):703-14. PubMed ID: 15094712 [Abstract] [Full Text] [Related]
15. Cleavage of osmosensitive transcriptional factor NFAT5 by Coxsackieviral protease 2A promotes viral replication. Qiu Y, Ye X, Zhang HM, Hanson P, Zhao G, Tong L, Xie R, Yang D. PLoS Pathog; 2017 Dec 15; 13(12):e1006744. PubMed ID: 29220410 [Abstract] [Full Text] [Related]
16. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response. Dai Q, He X, Yu H, Bai Y, Jiang L, Sheng H, Peng J, Wang M, Yu J, Zhang K. J Med Virol; 2021 Jun 15; 93(6):3581-3589. PubMed ID: 33336842 [Abstract] [Full Text] [Related]
17. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Li M, Yan K, Wei L, Yang J, Lu C, Xiong F, Zheng C, Xu W. Antiviral Res; 2015 Nov 15; 123():50-61. PubMed ID: 26343012 [Abstract] [Full Text] [Related]
18. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection. Hanson PJ, Hossain AR, Qiu Y, Zhang HM, Zhao G, Li C, Lin V, Sulaimon S, Vlok M, Fung G, Chen VH, Jan E, McManus BM, Granville DJ, Yang D. Front Cell Infect Microbiol; 2019 Nov 15; 9():265. PubMed ID: 31396490 [Abstract] [Full Text] [Related]
19. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA. Rani P, George B, V S, Biswas S, V M, Pal A, Rajmani RS, Das S. J Virol; 2024 Feb 20; 98(2):e0150423. PubMed ID: 38289119 [Abstract] [Full Text] [Related]
20. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model. Kim HG, Hillman PF, Lee YJ, Jeon HE, Lim BK, Nam SJ. Viruses; 2024 Apr 25; 16(5):. PubMed ID: 38793559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]